<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-<z:hpo ids='HP_0002861'>melanoma</z:hpo> <z:e sem="disease" ids="C0007114" disease_type="Neoplastic Process" abbrv="">skin cancers</z:e> (NMSCs) are the most commonly occurring <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in the United States, with over 1 million cases annually </plain></SENT>
<SENT sid="1" pm="."><plain>Several subsets of patients within the general population are particularly susceptible to the development of <z:hpo ids='HP_0002671'>basal cell carcinomas</z:hpo> and <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>These groups include patients with <z:e sem="disease" ids="C0043346" disease_type="Neoplastic Process" abbrv="">xeroderma pigmentosum</z:e>, <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome, <z:e sem="disease" ids="C0014522" disease_type="Neoplastic Process" abbrv="EV|EVER">epidermodysplasia verruciformis</z:e>, and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> as well as organ transplant recipients </plain></SENT>
<SENT sid="3" pm="."><plain>Organ transplant recipients are the largest and best characterized of these subsets of patients </plain></SENT>
<SENT sid="4" pm="."><plain>Review of the available data regarding the epidemiology, etiology, and clinical features of NMSC in organ transplant patients provides insight into the care of other high-risk patients </plain></SENT>
</text></document>